Sign in
4

Changes in Ownership

Aldeyra Therapeutics, Inc. Filed Acc 0000899243-21-023011

Options or other derivatives

  • Director acquired 14,117 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Miller-Rich Nancy Director 2021-06-08 Grant or award · Stock Option (Right to Buy) +13,534 13,534 D: show line 1 in the form
Miller-Rich Nancy Director 2021-06-08 Grant or award · Stock Option (Right to Buy) +583 583 D: show line 2 in the form
Loading xslF345X03/doc4.xml…